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Mutations in the rBAT gene cause type I cystinuria, a
common inherited aminoaciduria of cystine and dibasic
amino acids due to their defective renal and intestinal
reabsorption (Calonge, M. J., Gasparini, P., Chillarón, J.,
Chillón, M., Gallucci, M., Rousaud, F., Zelante, L., Testar,
X., Dallapiccola, B., Di Silverio, F., Barceló, P., Estivill,
X., Zorzano, A., Nunes, V., and Palacı́n, M. (1994) Nat.
Genet. 6, 420–426; Calonge, M. J., Volipini, V., Bisceglia,
L., Rousaud, F., De Sanctis, L., Beccia, E., Zelante, L.,
Testar, X., Zorzano, A., Estivill, X., Gasparini, P., Nunes,
V., and Palacı́n, M. (1995) Proc. Natl. Acad. Sci. U. S. A.
92, 9667–9671). One important question that remains to
be clarified is how the apparently non-concentrative
system bo,1-like, associated with rBAT expression, par-
ticipates in the active renal reabsorption of these amino
acids. Several studies have demonstrated exchange of
amino acids induced by rBAT in Xenopus oocytes. Here
we offer evidence that system bo,1-like is an obligatory
amino acid exchanger in oocytes and in the “renal prox-
imal tubular” cell line OK. System bo,1-like showed a 1:1
stoichiometry of exchange, and the hetero-exchange di-
basic (inward) with neutral (outward) amino acids were
favored in oocytes. Obligatory exchange of amino acids
via system bo,1-like fully explained the amino acid-in-
duced current in rBAT-injected oocytes. Exchange via
system bo,1-like is coupled enough to ensure a specific
accumulation of substrates until the complete replace-
ment of the internal oocyte substrates. Due to structural
and functional analogies of the cell surface antigen
4F2hc to rBAT, we tested for amino acid exchange via
system y1L-like. 4F2hc-injected oocytes accumulated
substrates to a level higher than CAT1-injected oocytes
(i.e. oocytes expressing system y1) and showed exchange
of amino acids with the substrate specificity of system
y1L and L-leucine-induced outward currents in the ab-
sence of extracellular sodium. In contrast to L-arginine,
system y1L-like did not mediate measurable L-leucine
efflux from the oocyte. We propose a role of systems
bo,1-like and y1L-like in the renal reabsorption of cys-
tine and dibasic amino acids that is based on their active
tertiary transport mechanism and on the apical and
basolateral localization of rBAT and 4F2hc, respec-
tively, in the epithelial cells of the proximal tubule of the
nephron.
Mutations in the human rBAT gene are responsible for clas-
sic cystinuria (1–3). This is a common inherited aminoaciduria
due to the defective transport of cystine and dibasic amino
acids through the epithelial cells of the renal tubule and intes-
tinal tract (4). Patients show urinary hyperexcretion of dibasic
amino acids and cystine but not of other neutral amino acids;
the low solubility of cystine leads to its precipitation and the
consequent formation of renal calculi (4). Three types of classic
cystinuria have been described on the basis of the amino acid
hyperexcretion of heterozygotes and the degree of the intestinal
transport defect (5–6). It has been demonstrated that rBAT is
only responsible for type I, where heterozygotes are silent
(7–8).
The rBAT protein is located in the brush border plasma
membrane of the proximal straight tubules of the nephron and
of the small intestine (9–10). Due to the role of rBAT in cystin-
uria, it is considered to be responsible for the reabsorption of
cystine and dibasic amino acids in the proximal straight tubule.
Human rBAT expressed in Xenopus oocytes elicits high affinity
sodium-independent transport of cystine, dibasic amino acids,
and some neutral amino acids via a bo,1-like transport system
(11–12). Very recently, the responsibility of rBAT for this
amino acid transport activity has also been demonstrated in
the “renal proximal tubular” cell line OK (13). We refer to this
as system bo,1-like, since this activity is very similar to system
bo,1 described in mouse blastocysts (14); these transport activ-
ities are not identical, since the latter does not transport L-
cystine. An electrogenic exchange diffusion mechanism for di-
basic and neutral amino acids has been reported for the
transport activity expressed by rabbit (15–16) and rat (17)
rBAT cRNA in oocytes. Coady and collaborators (16) showed
that neutral amino acids in the trans-side are needed to ob-
serve the currents associated with the transport of L-arginine
in oocytes expressing rabbit rBAT. Rennie and collaborators
(17) suggested that this hetero-exchange could not fully explain
the electric activity associated with the induced neutral amino
acid transport due to rat rBAT expression in oocytes. In addi-
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tion, it has been suggested that an exchange mechanism of
transport does not fit the proposed role for system bo,1-like/
rBAT in the active renal and intestinal amino acid reabsorption
(15, 16, 18). Therefore, the concentrative mechanism of amino
acid transport that explains the role of system bo,1-like in the
active renal reabsorption of dibasic amino acids and cystine
remains to be clarified. A further objective is the identification
of the transport mechanisms linking the structurally related
rBAT and 4F2hc proteins (19–20).
Here we offer evidence that system bo,1-like, associated with
rBAT expression in oocytes, is an obligatory amino acid ex-
changer that accumulates substrates as a tertiary amino acid
transporter. Hetero-exchange between dibasic and neutral
amino acids fully explains the electric activity associated with
the induced amino acid transport due to human rBAT expres-
sion in oocytes, and the exchange of dibasic amino acids (in-
ward) with neutral (outward) amino acids is favored. This
amino acid transport activity explains the role of rBAT/system
bo,1-like in cystinuria. In addition, we offer evidence that the
human cell surface antigen 4F2hc also induces, in oocytes, an
asymmetric obligatory amino acid exchanger (system y1L-like)
between dibasic (outward) and neutral amino acids (inward).
The participation of these two amino acid transport systems in
renal reabsorption is discussed.
MATERIALS AND METHODS
Oocytes, Injections, and cRNA Synthesis—Oocyte origin, manage-
ment, and injections were as described elsewhere (11). Defolliculated
stage VI Xenopus laevis oocytes were injected with saturating concen-
trations (1–5 ng/oocyte) of human rBAT, human 4F2hc, or mouse CAT1
cRNA. Except where indicated, noninjected oocytes were used as con-
trols; amino acid transport rates obtained with oocytes injected with
water (50 nl) were similar to those of uninjected oocytes (data not
shown). Synthesis of human rBAT, human 4F2hc (cDNA cloned in
EcoRI-HindIII pSPORT-1, from the original cDNA cloned in pSP65 by
Teixeira and collaborators (21)), and mouse CAT1 cRNAs is described
elsewhere (11, 22).
Oocyte Uptake Studies—Influx rate measurements of L-[3H]arginine,
L-[3H]leucine, and L-[35S]cystine (NEN Radiochemicals) were measured
in 100 mM NaCl or 100 mM choline Cl medium at the indicated days
after injection and in linear conditions as described elsewhere (11, 19,
23). When presented, cRNA (rBAT, 4F2hc, or CAT1)-induced uptake
was calculated by subtracting uptake values in uninjected oocytes from
those of the corresponding cRNA-injected oocytes.
For efflux rates measurements, 3 or 4 days after injection of the
corresponding cRNA, groups of 5–7 oocytes were incubated, at 25 °C, for
30 min (rBAT and CAT1 experiments) or 60 min (4F2hc experiments) in
medium containing 50 mM L-[3H]arginine or L-[3H]leucine (3–10 mCi/90
ml). More than 95% of the oocyte-soluble radioactivity corresponded to
the original labeled amino acid (see below). In five independent rBAT
experiments, this loading ranged between 145,000 and 295,000 cpm/
rBAT-injected oocyte and 139,000 and 315,000 cpm/rBAT-injected oo-
cyte for L-[3H]arginine and L-[3H]leucine uptakes, respectively. In the
4F2hc experiments (n 5 4), this loading ranged between 50,000 and
121,000 cpm/4F2hc-injected oocyte and 35,000 and 133,000 cpm/4F2hc-
injected oocyte for L-[3H]arginine and L-[3H]leucine uptakes, respec-
tively. For those experiments, loading of uninjected oocytes ranged
between 8,000 and 21,000 cpm/oocyte and 27,000 and 88,000 cpm/
oocyte for L-[3H] arginine and L- [3H]leucine uptakes, respectively. After
this loading, the radioactive medium was washed 4 times in choline
medium at 25 °C. Then, efflux was measured as the appearance of
tritium in unlabeled incubation medium (0.6–1 ml of sodium or choline
medium as indicated) containing no amino acids (none) or different
L-amino acids at the indicated concentrations. When L-cystine was used,
efflux was always measured in the presence of 10 mM diamide to
prevent L-cystine reduction. In these conditions, diamide did not affect
efflux by uninjected oocytes (data not shown). Efflux was measured
taking aliquots (200 ml) from the medium at zero time and at different
times. Efflux rates were calculated by subtracting the radioactivity
present at zero time. Previous studies demonstrated that after subtract-
ing the zero value the best fit line passed through the origin, and it was
linear for 1, 2, or 5 min for CAT1-injected, rBAT-injected, or 4F2hc-
injected oocytes, respectively (data not shown). Efflux rates are ex-
pressed either as the radioactivity (cpm 3 1,000) appearing in the
medium per unit time (2 or 5 min) per group of 5–7 oocytes, when
representative experiments are shown, or as the percent of the total
radioactivity loaded into the oocyte appearing in the medium per unit
time (2 or 5 min), when combined experiments are shown. Statistical
comparisons were performed using the Student’s t test.
In the accumulation studies, the radioactivity content of rBAT cRNA-
injected oocytes after 3 h incubation with L- [3H]arginine, L-[3H]leucine,
or L-[35S]cystine (in the presence of 10 mM diamide) was tested for
metabolization. Oocyte homogenates (choline medium) were precipi-
tated with 5% trichloroacetic acid. More than 97% of the radioactivity
from L-[3H]arginine- and L-[35S]cystine-incubated oocytes remained in
the soluble phase; for L-[3H]leucine-incubated oocytes 15% of the radio-
activity was trichloroacetic acid-precipitated, suggesting incorporation
into proteins. In the L-[35S]cystine experiments, oocytes were homoge-
nized in the presence of 20 mM N-ethylmaleimide (NEM)1 to analyze
L-[35S]cystine metabolites-NEM derivatives, as described elsewhere
(25). The soluble phase of trichloroacetic acid precipitation was ana-
lyzed by thin layer chromatography as described elsewhere (Ref. 26 for
L-[3H]arginine and L-[3H]leucine experiments and Ref. 25 for L-[35S]cys-
tine experiments). In all cases, .95% of the radioactivity showed the
same chromatographic mobility as the original incubated amino acids,
visualized with 0.2% ninhydrin in acetone (L-[3H]arginine and
L-[3H]leucine experiments) or by autoradiography (L-[35S]cystine exper-
iments) (data not shown). In the absence of diamide, almost all
L-[35S]cystine radioactivity was recovered, in both the oocytes and the
medium, as a product with identical chromatographic mobility to the
L-[35S]cysteine-NEM derivative.
As a reference value for the space distribution of amino acids in the
oocyte in the accumulation studies, the space distribution of water was
measured by incubating groups of 7–8 oocytes with [3H]water (2 mCi;
;2.4 3 106 cpm/90 ml; Amersham Corp.) for up to 30 min. After incu-
bation, oocytes were washed 3 times in ice-cold choline medium, and the
radioactivity of SDS-dissolved single oocytes was counted with scintil-
lation fluid in a b-radioactivity counter, as described elsewhere for
uptake studies in oocytes (23). The uptake of [3H]water increased from
30 s to 2 min and then reached a plateau (4,000–5,000 cpm), which was
maintained for the next 30 min. From this we estimated a space dis-
tribution of water in stage VI oocytes of 176 6 14 nl (mean 6 S.E. from
10 groups of oocytes in 2 independent experiments).
Oocyte Electric Measurements—Dissection of X. laevis, collection, and
handling of the oocytes was described in detail elsewhere (27). Oocytes
were injected with cRNA (1 ng/oocyte) or water, and two-electrode
voltage and current clamp recordings were performed 3–8 days later in
single oocytes in a perfused chamber, as described elsewhere (15). The
external control solution (ND96 medium) contained 96 mM NaCl, 2 mM
KCl, 1.8 mM CaCl2, and 5 mM HEPES at pH 7.5. In some experiments,
Na1 was replaced by choline. The amino acids were added to the
solution at the indicated concentrations, and the tested oocyte was
perfused at 20 ml/min, which guaranteed a complete solution exchange
in the recording chamber within 10–15 s. The maximal current ampli-
tude induced during amino acid superfusion was measured. Inward
currents are shown with the prefix -. All data are given as means (6
S.E.), where n gives the number of oocyte measurements. Statistical
comparisons were performed using the Student’s t test. Experiments
were repeated with 2 batches of oocytes; in all repetitions, qualitatively
similar data were obtained.
OK Cell Studies—The OK cell line clone 3B/2 (28), derived by selec-
tion from the original OK cells (29), between passages 16 and 21, was
used in this study. Selected OK cell clones (13) that express human
rBAT antisense (AS1) and sense (S1) sequences after permanent trans-
fection of a 669-base pair EcoRI/ClaI fragment from the 59-end of the
full-length human rBAT cDNA (11) were also used. Cell culture condi-
tions were as described (13, 30).
Efflux rates measurements of L-[3H]arginine into MGA medium (137
mM N-methyl-D-glucamine, 5.4 mM KCl, 2.8 mM CaCl2, 1.2 mM MgSO4,
10 mM HEPES, pH 7.4) containing or not containing unlabeled L-amino
acids were as described elsewhere (13). Results are expressed as cpm,
corrected per 150,000 cpm loaded/mg of proteinzmin. Statistical com-
parisons were done using the Student’s t test. Thin layer chromatogra-
phy analysis (26) of the efflux medium revealed that ;95% of the efflux
radioactivity corresponded to L-arginine (data not shown).
Simulation of the bo,1-like Amino Acid Exchanger—To simulate the
L-3H-amino-acid, accumulation experiments were performed in oocytes
expressing the human rBAT cRNA; we constructed a model based on
1 The abbreviations used are: NEM, N-ethylmaleimide; CAT1, cati-
onic amino acid transporter 1.
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the following premises. 1) The induced amino acid transport activity is
an obligatory exchanger of dibasic and neutral amino acids with a 1:1
stoichiometry. 2) An endogenous, independent, and equilibrative trans-
port system is necessary to explain the amino acid transport of unin-
jected oocytes. Fig. 1 shows the obligatory exchange “ping-pong” mech-
anism considered here for system bo,1-like. An alternative concerted
mechanism of obligatory exchange, tested in parallel, gave similar
results for the accumulation behavior to the ping-pong mechanism. The
computer program written to simulate the amino acid transport activity
in oocytes expressing rBAT is available upon request.
The simulation was prepared according to the following steps.
(i) Characteristics of the simulated system. The experimental system
of L-[3H]arginine accumulation studies (Fig. 5) was reproduced as two
separate compartments of 90 ml (the outside, uptake medium) and 180
nl per oocyte (the inside, the space distribution for [3H]water, see
above). Initial inner concentrations of the amino acid substrates of
system bo,1-like for stage VI Xenopus oocytes were set according to
Taylor and Smith (31). The concentrations of L-arginine (and L-[3H]argi-
nine), L-leucine, and L-cystine were treated individually, whereas the
rest of the amino acids were considered in two groups, neutral and
dibasic. Transport rates were evaluated from the relative concentra-
tions of transporter binary and empty complexes at either side, accord-
ing to the formalism of Cha (32), which allows us to combine equilib-
rium and steady-state steps in a single mechanism. Binding steps were
considered as equilibria (defined as dissociation constants, Ko, outside
and Ki, inside), whereas translocation steps were considered as steady-
state (defined as two translocation rate constants, kin, kout) (Fig. 1).
During the simulation, amino acid concentrations at either side were
modified by numerical integration of the transport rates. The equilib-
rium assumptions do not significantly alter the calculated rates with
respect to a full steady-state mechanism. For the experiment shown in
Fig. 6, superfusion experimental conditions were simulated by fixing
the external concentrations to the initial values, and only internal
concentrations were changed. This is reasonable as the external solu-
tion is exchanged in 10–15 s (see above).
The transport rates of dibasic amino acids are markedly influenced
by the membrane potential (F). The effect of this parameter was intro-
duced by modification of dissociation and translocation constants ac-
cording to the following equation:
Pi5Pi0exp$­ZiPF/pRT% (Eq. 1)
where Pi is the given parameter, Pi
0, its value at zero potential, Zi, the
amino acid charge, F, 96,500 coulomb/mol, R, 8.31 J/molzK, and T, the
absolute temperature (fixed to 298 K), n was set to 1 for equilibrium
constants, and 2 for rate constants. ­ represents the effective fraction of
the membrane potential that influences the step indicated by P. This
fraction was arbitrarily set to 0.2 for binding and to 0.6 for translocation
steps. This parameter (­) has little influence on the accumulation
curves (data not shown). Membrane potential was fixed to 250 mV for
resting oocytes and to 235 mV for 50 mM L-arginine uptake (see legend
to Fig. 5). Initial potentials for other concentrations were varied accord-
ing to the expected initial rates. The membrane potential was returned
to the resting value after some time (see legend to Fig. 5). This effect
was also included in the simulation by using a time constant of 100 min,
which is a good representation of the experimental evolution.
(ii) Amino acid kinetic parameters. The simulation system prepared
as indicated above permits us to follow the evolution of amino acid
concentrations and, therefore, to simulate experimental influx and ef-
flux rates in any experimental condition. However, before using the
system, values are required for the kinetic parameters (see Fig. 1) for
every amino acid and the concentration of transporters. No direct ex-
perimental determination of transporter concentration is available;
therefore, Vmax values as reported in Table I represent inseparable
combinations of the transporter concentration and the translocation
constants. For this reason, the translocation constants (kin and kout) for
L-arginine were set arbitrarily to 1, and used as reference. The trans-
location constants for the remaining amino acids were then used as
relative values. In this way, changes in the transporter concentration
are represented by a single parameter (adjusted as indicated below),
which affects every amino acid in the right proportion.
Relative values of translocation constants were estimated as follows.
The efflux rates determined according to the experiment of Fig. 2 were
simulated using several combinations of parameters. An analytic de-
pendence of the calculated rates and the parameters was then deduced,
and the best estimates of the parameters were obtained. Apparent
parameters for the pools of neutral or dibasic amino acid were obtained
by averaging the individual values of each amino acid at its relative
concentration. The whole simulation and fitting cycle was repeated
until self-consistence. The final values of the relative translocation
constants (kin 5 kout) at zero membrane potential were 2.1 for L-leucine,
1.05 for the pool of neutral amino acids, and 0.78 for the pool of dibasic
amino acids. Dissociation constants (Ko, Ki) were set to 90 mM for all the
amino acids, according to the external apparent Km values obtained
(Table I). Due to the high internal concentrations of substrates, the
bo,1-like transporter remained saturated during the simulation. There-
fore, the precise values of the internal dissociation constants have little
influence on the results obtained.
(iii) Simulation of the accumulation experiments. To reproduce accu-
mulation studies shown in Fig. 5, first the concentration and kinetic
parameters of the endogenous transporter were manually adjusted to
reproduce the accumulation curves obtained in uninjected oocytes (see
legend to Fig. 5). Second, in the presence of this endogenous activity, the
Vmax of L-arginine influx, which includes the concentration of b
o,1-like
transporter and the actual value of the L-arginine translocation con-
stant, was set to fit the initial influx rates of rBAT-injected oocytes (see
legend to Fig. 5). Finally, with the concentrations chosen and the
parameters indicated above the system was simulated for the desired
time.
RESULTS
Substrate Specificity and Kinetic Parameters of the bo,1-like
Amino Acid Exchanger Expressed in Oocytes—Several studies
have suggested that the amino acid transport system bo,1-like,
associated with rBAT expression in oocytes, is an amino acid
exchanger (15–17). If this is correct, the substrate specificity
and the apparent kinetic parameters should be identical when
influx or the amino acid-dependent stimulation of efflux are
measured. The efflux of L-[3H]arginine via system bo,1-like in
rBAT-injected oocytes was stimulated by amino acids in the
external medium with the same substrate specificity shown in
uptake studies (influx) through this transport activity (Fig.
2A). Thus, 1 mM dibasic and neutral L-amino acids (or 200 mM
L-cystine) in the external medium, which are substrates for
system bo,1-like (23, 33–35), increased efflux of L-arginine in
rBAT-injected but not in uninjected oocytes. L-Proline and L-
glutamate, which are not substrates for system bo,1-like (23,
33–34), did not increase efflux of L-[3H]arginine in rBAT-in-
jected oocytes (Fig. 2A). Similar data of substrate specificity
FIG. 1. Reaction mechanism for the amino acid exchanger
model. A ping-pong mechanism (only one amino acid, either A or B, is
transported at once) of obligatory exchange is shown. Binding steps
were considered as equilibria (defined as dissociation constants Ko and
Ki), whereas translocation steps were considered as steady state (de-
fined as two translocation rate constants kin, kout). The system has been
assumed to be symmetric (i.e. kin 5 kout, Ko 5 Ki). The equilibrium
assumptions do not significantly alter the calculated rates with respect
to a full steady-state mechanism. Translocation of the empty trans-
porter (To, facing outside; Ti, facing inside) is not considered, since
system bo,1-like is assumed to be an obligatory exchanger. The same
mechanism of transport was used for the endogenous transporter but
allowing free translocation of the empty transporter, as this is consid-
ered an equilibrative system.
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were obtained when the efflux rates of L-[3H]leucine were
measured (data not shown). The efflux rates of L-[3H]arginine
and L-[3H]leucine from several experiments, and expressed as
percent of the previous loading, are shown in Fig. 2B. The
efflux rates of L-[3H]leucine into amino acid-free medium were
identical in rBAT-injected and uninjected oocytes, whereas
they were increased #7-fold by 1 mM L-arginine only in oocytes
expressing rBAT (Fig. 2B). This supports the idea that system
bo,1-like is an obligatory amino acid exchanger; transport via
system bo,1-like occurs only when substrates are present on the
trans-side. A similar interpretation of the efflux rates of
L-[3H]arginine is difficult to postulate. The efflux rates of
L-[3H]arginine, expressed as percent of the previous loading,
into medium containing no amino acids in rBAT-injected (;1%
in 2 min) are lower than in uninjected oocytes (.3% in 2 min)
(Fig. 2B). This suggests that either rBAT expression results in
the retention of L-arginine inside the oocyte or L-[3H]arginine
uptake reaches two different pools in the oocyte, one of these
pools being quantitatively important for the uptake measured
in uninjected oocytes but not in rBAT-injected oocytes. In any
case, L-[3H]arginine efflux was increased 8-fold by 1 mM L-
arginine only in oocytes expressing rBAT (Fig. 2B). This dem-
onstrates that L- [3H]arginine efflux via system bo,1-like is also
dependent on the presence of amino acid substrates on the
trans-side.
Next, the kinetic parameters of the amino acid transport
activity (efflux and influx) induced by rBAT in oocytes were
measured. L-Arginine- and L-leucine-elicited efflux of
L-[3H]arginine showed saturability (data not shown) with sim-
ilar apparent Km values for the external amino acids (Table I).
Interestingly, the apparent Km values for L-arginine and L-
leucine either acting as substrates for influx or stimulating
efflux of L-[3H]arginine were similar (mM range, Table I). This is
expected for an obligatory exchanger, and it is inconsistent
with an allosteric mechanism of trans-stimulation of efflux. For
all the substrates, when efflux or influx was measured, the Hill
coefficient was never significantly different from 1 (data not
shown), suggesting interaction of one molecule of external sub-
strate per functional molecular unit of transporter. The Vmax
values for influx via system bo,1-like in oocytes ordered the
three substrates considered as follows, L-arginine . L-leucine
.. L-cystine. Comparison of this with the potency of these
amino acids to elicit L-arginine efflux (Fig. 2A and Table I)
suggested that in the hetero-exchange events via system bo,1-
like the “slowest” substrate (i.e. L-cystine) limits the transport
activity.
The System bo,1-like Associated with rBAT Expression in OK
Cells also Behaves as an Amino Acid Exchanger—We have
shown in a previous study that the rBAT gene is necessary for
the amino acid transport system bo,1-like activity in the apical
pole of the renal proximal tubular cell line OK; permanent
transfection of antisense rBAT sequences results in a specific
decrease (60% inhibition in the antisense clone AS1 but not in
the sense clone S1) in this transport activity (13). The substrate
specificity of the stimulation of L-[3H]arginine efflux in OK cells
FIG. 2. L- [3H]Arginine and L- [3H]leucine efflux via amino acid
transport system bo,1-like in oocytes. Oocytes were injected with 5
ng of rBAT cRNA (black bars) or uninjected oocytes (open bars). Four
days later, amino acid efflux rates were measured in choline medium
containing no amino acids (none) or the indicated 1 mM L-amino acids.
200 mM L-cystine (CssC) was used in the presence of 10 mM diamide. A,
L- [3H]arginine efflux rates (expressed as the radioactivity (cpm 3
1,000) appearing into the medium per 2 min per group of 6 oocytes)
correspond to the mean 6 S.E. of triplicates from a representative
experiment. All the L-amino acids, but L-proline and L-glutamate, in the
medium significantly increased efflux from rBAT cRNA-injected, but
not from uninjected oocytes (p # 0.01). B, L-[3H]Arginine and
L-[3H]leucine efflux rates into unlabeled medium containing no amino
acids (none) or 1 mM L-arginine (Arg) from rBAT cRNA-injected or
uninjected oocytes. Efflux rates (i.e. radioactivity appearing in the
medium/2 min) are expressed as percent of the total radioactivity
loaded into the oocyte. Data (mean 6 S.E.) are from 9–12 determina-
tions (5 independent experiments, L-arginine efflux) and from 9 deter-
minations (3 independent experiments, L-leucine efflux). L-Arginine
significantly induced L-[3H]arginine and L-[3H]leucine efflux from rBAT
cRNA-injected (p # 0.001) but not from uninjected oocytes. L-[3H]Argi-
nine efflux into medium containing no amino acids (none) was lower
from rBAT cRNA-injected than from uninjected oocytes (p # 0.001),
whereas L-[3H]leucine efflux into medium containing no amino acids
(none) was similar in the two groups.
TABLE I
Kinetic parameters of system b0,1-like amino acid exchanger activity
associated with rBAT expression in oocytes
rBAT-induced influx rates for L-cystine, L-arginine, and L-leucine
were measured 3–4 days after injection of rBAT cRNA (5 ng/oocyte) at
7–8 different substrate concentrations (10–250 mM) and calculated as
described under “Materials and Methods.” The amino acid-elicited
L-[3H]arginine efflux rates were assayed at 6-different concentrations
(10–1,000 mM) of the external substrate and calculated by subtracting
the rates of efflux into medium containing no amino acids. Km for efflux
represents the concentration of external amino acid needed for the
semi-maximal amino acid-elicited efflux. Influx data (mean 6 S.E.)
correspond to representative kinetic experiments run in triplicate. Ef-
flux data (mean 6 S.E.) correspond to 3–6 determinations from 3
independent experiments. ND, not determined.
Substrate L-Cystine L-Arginine L-Leucine
Influx
Km (mM) 41 6 7 85 6 7 90 6 12
Vmax (pmol/min/oocyte) 9 6 1 211 6 11 59 6 4
Efflux (L-arginine)
Km (mM) ND 65 6 5 67 6 26
Vmax (% oocyte loading/2 min) ND 6.1 6 0.2 2.9 6 0.6
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was similar to that of system bo,1-like expressed in oocytes
(Figs. 2A and 3). L-Leucine-elicited L-[3H]arginine efflux de-
creased by 60% in the rBAT antisense-transfected clone
(16,800 6 2,400 and 6,500 6 700 cpm/mg proteinzmin in the
rBAT-sense S1 and rBAT-antisense AS1 clones respectively,
n 5 6). In contrast, L-[3H]arginine efflux into medium contain-
ing 1 mM L-glutamate, which is not a system bo,1-like substrate
(Figs. 2A and 3), was not affected by antisense expression
(L-[3H]arginine efflux was 1,490 6 840 and 1,480 6 580 cpm/mg
proteinzmin in the rBAT-sense S1 and rBAT-antisense AS1
clones, respectively, n 5 6). This indicates that L-[3H]arginine
efflux via system bo,1-like does not occur in the absence of
substrates in the medium and demonstrates that L-leucine-
elicited L- [3H]arginine efflux occurs via system bo,1-like (asso-
ciated with rBAT expression). Kinetic analysis of this efflux
showed saturability via a single component with an apparent
Km value of 295 6 64 mM (data not shown). This value fits
reasonably well with the estimated apparent Km value for the
influx of L-leucine through the component inhibited by L-argi-
nine (175 6 56 mM; Ref. 13). Then, as already shown in the
oocyte studies, system bo,1-like associated with rBAT behaves
as an obligatory exchanger in OK cells.
The System bo,1-like Accumulates Its Substrates in the Oo-
cytes as a Tertiary Active Transporter—An obligatory amino
acid exchanger is considered a tertiary active transport mech-
anism; it accumulates substrates as a result of exchange with
amino acids on the trans-side. It has been reported that stage
VI Xenopus oocytes contain a high amount of free amino acids
that are substrates of system bo,1-like (31). If the degree of
coupling of exchange of system bo,1-like expressed in oocytes is
high enough, uptake via this system should result in the accu-
mulation of these substrates in the oocyte. Uptake studies of 50
mM L-[3H]arginine, L-[3H]leucine, or L-[35S]cystine during long
incubation periods (3–6 h) showed a higher plateau of accumu-
lation of these substrates in oocytes expressing rBAT than in
uninjected or CAT1-injected oocytes (i.e. oocytes expressing the
dibasic amino acid transport y1; Ref. 22) (data not shown and
Fig. 4). Similarly, L- [3H]arginine accumulation reached higher
levels in 4F2hc-injected oocytes than in uninjected or CAT1-
injected oocytes (data not shown); these data are discussed
below. Similar uptake values by rBAT-injected oocytes were
obtained in the absence and in the presence of sodium (data not
shown). With an oocyte space distribution for polar substrates
of ;180 nl (see “Material and Methods”), the plateau of uptake
values of 50 mM L-[3H]arginine uptake represents a 55-fold
accumulation (;40-fold for L-[3H]leucine or L-[35S]cystine up-
take) of the substrate in rBAT-injected oocytes (Table II). In
contrast, the level of L-[3H]arginine accumulation in CAT1-
injected and in uninjected oocytes was 14–20-fold (Table II).
This demonstrates that under these conditions accumulation
of substrates via system bo,1-like is clearly higher than via
system y1.
If the accumulation of substrates via system bo,1-like is due
to exchange with the intracellular oocyte substrates, their total
oocyte content (;1,000 pmol/oocyte; Ref. 31) would limit this
accumulation. The increase in L-[3H]arginine concentration
from 10 to 1,000 mM resulted in a nonlinear increase in L-
arginine accumulation, which reached a maximum of #1,000
pmol/oocyte at ;500 mM L-arginine (Fig. 4). This is at odds with
the uptake via system y1, associated with CAT1 expression,
which increased from ;140 pmol/oocyte at equilibrium with 50
mM L-[3H]arginine to ;750 pmol/oocyte, without reaching equi-
librium after 4 h, with 500 mM L-[3H]arginine (data not shown).
This level of L-arginine uptake is nearly 4 times the reported
dibasic amino acid content of stage VI oocytes (31). To test
whether a tertiary active transport mechanism could explain
the accumulation of substrates in rBAT-injected oocytes, we
simulated the L- [3H]arginine accumulation curves shown in
Fig. 4 with a model that considers system bo,1-like as an
obligatory exchanger with 1:1 stoichiometry (see “Material and
Methods”). Interestingly, this modeling reproduces the experi-
mental results (see lines in Fig. 4). At the highest L-[3H]argin-
ine concentration used (i.e. 1 mM), the model predicts that at
equilibrium nearly 98% of the internal substrates of system
bo,1-like have been replaced by L-arginine with the initial spe-
FIG. 3. L- [3H]Arginine efflux in OK cells. L-[3H]Arginine efflux
rates were measured in media containing no amino acids (none) or the
indicated L-amino acids at 1 mM, except for L-cystine (CssC), which was
present at 200 mM plus 5 mM diamide (as controls, cells were incubated
in amino acid-free medium plus 5 mM diamide, hatched bar). Efflux
rates (mean 6 S.E.) are cpm 3 1,000 measured in the medium (correct-
ed for 150,000 cpm loaded into the cells)/mg of protein per min from 3
to 12 determinations (5 independent experiments). Data for L-lysine
and L-phenylalanine groups are the mean from two determinations in a
representative experiment. Efflux rates in the L-cystine, L-leucine, and
L-arginine groups were significantly different (p # 0.05) from those of
the none, L-proline, and L-glutamate groups.
FIG. 4. Concentration dependence of L-arginine accumulation
in rBAT-injected oocytes. Oocytes were injected with 5 ng of rBAT
cRNA or uninjected (not shown). Three days later the uptake of
L-[3H]arginine (3–5 mCi/90 ml) was measured at 10 (open circles), 50
(closed circles), 500 (open squares), and 1,000 (closed squares) mM con-
centration of substrate for the time indicated and in sodium uptake
medium. Simulations (curved lines) of the accumulation progress for the
rBAT-injected oocytes were estimated with the obligatory exchange
mechanism described under “Materials and Methods.” The Vmax for
bo,1-like transport activity was adjusted to fit the influx velocity of
L-[3H]arginine by rBAT-injected oocytes measured in this experiment.
The endogenous transport activity was adjusted to reproduce the influx
velocity of L-arginine (3.8 6 0.4, 4.9 6 0.7, 7.0 6 0.8, and 16.5 6 1.3
pmol/5 min per oocyte at 10, 50, 500, and 1,000 mM L-[3H]arginine), the
evolution of the accumulation curves, and the plateau of accumulation
(;30, ;125, ;160, and ;230 pmol in 4 h per oocyte at 10, 50, 500, and
1,000 mM L-[3H]arginine) for the uninjected oocytes measured in this
experiment; at 500 and 1,000 mM concentrations, the uptake in unin-
jected oocytes increased over the time (4 h) assayed without reaching a
plateau. The total content of internal substrates for system bo,1-like
(31) is shown by a horizontal dashed line. The uptake data (pmol/oocyte)
are the mean 6 S.E. from 7 oocytes in a representative experiment.
When not visible the errors are smaller than symbols. Similar data
were obtained in another two independent experiments.
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cific activity of the substrate and with hardly any change in the
total substrate content of the oocyte (Table III). Similarly, the
model also predicts that superfusion (20 ml/min) of rBAT-
injected oocytes with 50 mM L-arginine or L-leucine for 3 h
results in 95 and 79% replacement of the internal oocyte sys-
tem bo,1-like substrates, respectively (data not shown). The
main conclusion of this theoretical study is that accumulation
of L-[3H]arginine in rBAT-injected oocytes can be fully ex-
plained by an obligatory exchanger of 1:1 stoichiometry, in
which the driving force of the accumulation is the high internal
concentration of amino acids. An interesting consequence of
this is that we can almost completely exchange the internal
content of substrates of system bo,1-like and then estimate the
influx and efflux rates through the transporter under condi-
tions of homogeneous exchange of substrates.
This was tested experimentally. Indeed, continuous superfu-
sion of rBAT-injected oocytes with 50 mM L-arginine or L-leucine
for 3 h resulted in a dramatic decrease in the inward positive
current elicited by L-arginine and the outward positive current
elicited by L-leucine, respectively (Fig. 5). In these conditions,
L-arginine- and L-leucine-induced currents tended to be zero.
This indicates that all the electric activity of system bo,1-like is
due to the hetero-exchange between neutral and dibasic amino
acids and that the stoichiometry of the amino acid homo-ex-
change is n:n. In contrast, superfusion with L-arginine in-
creased the L-leucine-induced currents, and superfusion with
L-leucine increased L-arginine-induced currents (Fig. 5). In
these conditions, at 250 mV membrane potential, the maximal
L-arginine-induced currents (i.e. by exchange with the internal
L-leucine) are approximately twice as strong as the maximal
L-leucine-induced currents (i.e. by exchange with the internal
L-arginine). This demonstrates that the exchange via system
bo,1-like of L-arginine inward:L-leucine outward is favored ver-
sus the reverse direction.
To determine the stoichiometry of the exchange of amino
acids via system bo,1-like, rBAT-injected oocytes were incu-
bated for 4 h with 1 mM labeled (L-[3H]arginine or L-
[3H]leucine) or the corresponding unlabeled substrates, and
influx and L-amino acid-elicited efflux transport rates were
measured immediately. Fig. 6 shows that, for every type of
homo- and hetero-exchange between L-arginine and L-leucine,
the transport rates for influx and for the L-amino acid-elicited
efflux were identical. This demonstrates an n:n stoichiometry
for the obligatory exchange of amino acids via system bo,1-like.
This stoichiometry is most probably 1:1 since for all the kinetic
studies of L-arginine and L-leucine influx and efflux transport
rates, the Hill coefficient was never different from 1 (data not
shown). Again, the hetero-exchange L-arginine inward:L-
leucine outward is favored versus the reverse direction of
exchange (Fig. 6).
The Amino Acid Transport System y1L-like Behaves as an
Obligatory Exchanger with Asymmetry—Due to the structural
and functional homology between rBAT and 4F2hc, we tested
for the accumulation of substrates in 4F2hc-injected oocytes.
As indicated above, uptake of 50 mM L-[3H]arginine or
L-[3H]leucine reached levels of accumulation in 4F2hc-injected
oocytes higher that those obtained via system y1 or in unin-
jected oocytes (Table II). These data demonstrated an active
mechanism of transport for system y1L-like associated with
4F2hc expression in oocytes. Interestingly, L-arginine and L-
leucine, but not L-tryptophan, in the medium stimulated efflux
of L-[3H]arginine via system y1L-like, associated with 4F2hc
expression in oocytes (Fig. 7A). As already shown (Fig. 2), these
amino acids did not stimulate efflux in uninjected oocytes (Fig.
7). L-Leucine-elicited efflux of L-[3H]arginine in 4F2hc-injected
oocytes was barely detectable at 0.1 mM in the absence of
sodium (choline medium), but it increased dramatically in the
presence of sodium; the sodium effect was much less apparent
at 10 mM L-leucine (Fig. 7A). This substrate specificity corre-
sponds to that of influx via system y1L-like in oocytes. Thus,
the 4F2hc-induced influx of 100 mM L-[3H]leucine was 1 6 0.3
pmol/5 min per oocyte in the absence of sodium, and 34 6 3
pmol/5 min per oocyte in the presence of 100 mM sodium (n 5
6 oocytes). In agreement with this, the y1L amino acid trans-
port activity described in human erythrocytes and placenta
carries dibasic amino acids with high affinity, neutral amino
acids, like L-leucine, with high affinity only in the presence of
sodium, but not L-tryptophan (36–38). All this demonstrated
that efflux via the y1L-like transport activity associated with
4F2hc expression in oocytes is highly dependent on the pres-
ence of substrates on the trans-side. This, together with the
effective accumulation of substrates, such as L-arginine and
L-leucine, in oocytes expressing 4F2hc strongly suggests that
system y1L-like is a tertiary active amino acid transport sys-
tem with an obligatory exchanger mechanism.
Next, we studied L-[3H]leucine efflux via system y1L-like
associated with 4F2hc expression in oocytes. To our surprise,
L-[3H]leucine efflux was not stimulated by external L-arginine
(Fig. 7B) or L-leucine (data not shown). Thus, efflux rates,
expressed as percent of the radioactivity loaded per 5 min, by
4F2hc-injected (3.3% 6 0.2 in the absence of external amino
acids and 3.4% 6 0.3 in the presence of 1 mM L-arginine, n 5 3
TABLE II
Accumulated gradient of amino acids at equilibrium
Oocytes were injected (1–5 ng/oocyte) with cRNA (rBAT, 4F2hc, or
CAT1) or noninjected, 3–4 days later the uptake of 50 mM L-[35S]cystine.
L-[3H]leucine, or L-[3H]arginine was measured in groups of 6–8 oocytes
at equilibrium (i.e. 3–6 h of uptake incubations). The accumulated
gradient of substrates into the oocyte expressed as times the initial
concentration of substrate in the medium, was calculated assuming a
space distribution of [3H]water of 176 nl (see “Materials and Methods”).
Data for rBAT-, CAT1-, and uninjected oocytes are the mean 6 S.E.
corresponding to 6–15 determinations (3–7 independent experiments).
4F2hc and L cystine (rBAT) data are the mean values (3–6 determina-
tions) in two independent experiments.
Substrate Un-injected rBAT 4F2hc CAT1
L-Arginine 14 6 1 55 6 5 34, 39 19 6 2
L-Leucine 19 6 3 48 6 11 27, 37
L-Cystine 1.1 6 0.6 40, 42
TABLE III
Simulated internal concentrations and specific activities during L-
[3H]arginine accumulation in oocytes expressing rBAT
The internal concentration (mM and % of total substrates of system
b0,1-like) of the analyzed groups of amino acids at time 5 0 (values from
Ref. 31) and after 4 h of 1,000 mM L-[3H]arginine uptake in rBAT-
injected oocytes are shown (upper). The evolution of the external and
internal specific activity of L-[3H]arginine is also indicated (lower). The
initial specific activity of L-[3H]arginine, defined as (labeled L-arginine)/
(total L-arginine), was set to 0.0001. The actual value of the specific
activity does not alter the conclusion, provided that the concentration of
labeled L-[3H]arginine does not significantly change the total L-arginine
concentration.
Internal concentration (mM)
Time 5 0 Time 5 4 h
L-Arginine 697 5653.0 (97.7%)
L-Leucine 231 3.1 (0.05%)
L-Neutral 4288 64.3 (1.1%)
L-Dibasic 574 63.0 (1.1%)
Total 5790 5783.4
L-[3H]Arginine specific activity (3105)
Time 5 0 Time 5 4 h
External 10 9.90
Internal 0 9.88
Amino Acid Exchange via Systems bo,1 and y1L-like17766
independent experiments) and uninjected oocytes (3.6% 6 0.7
in the absence of external amino acids and 3.2% 6 0.9 in the
presence of 1 mM L-arginine) were similar. This is at odds with
the #7-fold increase in L- [3H]leucine efflux due to trans-L-
arginine in rBAT-injected oocytes (Fig. 2B). This demonstrates
functional asymmetry of the amino acid exchange via system
y1L-like expressed in oocytes and suggests that hetero-ex-
change of arginine inward/neutral amino acid outward, if it
occurs, is clearly weaker than the reverse hetero-exchange. To
provide further evidence for amino acid hetero-exchange (i.e.
neutral inward/dibasic outward) via system y1L-like, the elec-
trogenicity of this system was studied in 4F2hc-injected oo-
cytes. These oocytes, but not uninjected oocytes, showed a
small but significant and reproducible positive outward current
when 10 mM L-leucine was present in the external medium in
the absence of sodium (1.2 6 0.1 and 20.1 6 0.1 nA for 4F2hc-
injected and uninjected oocytes, respectively, n 5 7–8 oocytes,
p # 0.01). In the presence of sodium, this current was not
detectable (21.7 6 0.2 and 21.8 6 0.3 nA for 4F2hc-injected
and uninjected oocytes, respectively, n 5 7–8 oocytes). This is
most probably due to the activity of an endogenous sodium-de-
pendent transporter for leucine and/or co-transport of sodium
with L-leucine via system y1L-like. In agreement with this, it
has been shown that the placenta system y1L is largely insen-
sitive to alterations of the membrane potential, suggesting
co-transport of sodium and L-neutral amino acids (38).
DISCUSSION
We have shown that amino acid transport systems bo,1-like,
associated with rBAT expression in oocytes and OK cells, and
y1L-like, associated with 4F2hc expression in oocytes, are
highly coupled obligatory exchangers (i.e. tertiary active trans-
porters). The exchange via systems bo,1-like and y1L-like is
asymmetric, favoring the uptake and the release of dibasic
amino acids, respectively. This offers a functional explanation
for the role of system bo,1-like in type I cystinuria and allows us
to propose a role of system y1L in the active efflux of dibasic
amino acids.
Several studies have shown induction of the exchange of
amino acids in oocytes expressing rabbit and rat rBAT expres-
sion (15–17). Coady and collaborators (16) described an oblig-
atory hetero-exchange mechanism between dibasic and neutral
amino acids via system bo,1-like to explain the currents asso-
ciated with the function of this transport system in oocytes. In
contrast, Rennie and collaborators (17) suggested that this
hetero-exchange could not fully explain the electric activity
associated with the induced transport of neutral amino acids
due to rat rBAT expression in oocytes. Here we demonstrate
that the amino acid transport activity induced by human rBAT
in oocytes can be fully explained by system bo,1-like activity, as
FIG. 5. Effect of L-arginine and L-leucine superfusion on L-
amino acid-induced currents in rBAT-injected oocytes. Oocytes
were injected with 1 ng of rBAT cRNA. 50 mM L-arginine-induced and 50
mM L-leucine-induced currents were measured, at a clamped potential of
250 mV, before and after 3 h superfusion with 50 mM L-arginine (upper
graph, 8 days after injections) or with 50 mM L-leucine (lower graph, 3
days after injections). In current clamped conditions, the membrane
resting potential (254 6 3 and 260 6 2 mV in the L-arginine and
L-leucine superfusion experiments, respectively) was immediately de-
polarized to 233 6 3 mV by L-arginine and repolarized to 266 6 6 mV
by L-leucine. After 3 h of 50 mM L-amino acid superfusion, the membrane
potential was almost restored to 246 6 4 mV (L-arginine superfusion
experiment) and to 260 6 3 mV (L-leucine superfusion experiment).
The whole protocol was performed in sodium ND96 medium. Data (nA)
are the mean 6 S.E. from 5 oocytes (L-arginine superfusion) and 4
oocytes (L-leucine superfusion) from two different batches.
FIG. 6. Efflux and influx transport rates via system bo,1-like in
rBAT-injected oocytes. Oocytes were injected with 5 ng of rBAT
cRNA or uninjected, and 4 days later they were assayed for efflux
(closed bars) and influx (open bars) transport of the indicated amino
acids in the oocyte schemes shown at the foot of the figure. For efflux
studies, groups of 7 oocytes were incubated in choline uptake medium
for 4 h in the presence of 1 mM L-[3H]arginine or L- [3H]leucine (3 mCi/90
ml). Then efflux rates were measured in the absence or in the presence
of the indicated 250 mM L-amino acids. For influx studies, groups of 7
oocytes were incubated in choline uptake medium (90 ml) for 4 h in the
presence of 1 mM cold L-arginine or L-leucine. Then media were removed
and the oocytes were washed as indicated for efflux studies. Influx of
250 mM L-[3H]arginine or L-[3H]leucine were immediately assayed for 2
min. Efflux data correspond to the amino acid-elicited efflux rates (i.e.
efflux into media containing amino acids minus efflux into medium
containing no amino acids). To express efflux rates as pmol/2 min per
oocyte, the initial specific activity of the tracer during the accumulation
phase of the study was used (see Table III). Influx rates correspond to
the rBAT-induced transport activity (i.e. transport in rBAT-injected
minus that in uninjected oocytes). Data (mean 6 S.E.) are from 4
(efflux) and 12–14 (influx) determinations from a representative exper-
iment. The corresponding efflux and influx rates ere not significantly
different in the four groups. Efflux and influx rates in the hetero-
exchange Leu (outward)/Arg (inward) were significantly higher (p #
0.01) than those corresponding to the reverse hetero-exchange.
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an obligatory exchanger, most probably with 1(inward):1(out-
ward) stoichiometry for the homo- and hetero-exchange of its
amino acid substrates. In addition, the expression of the rBAT
gene in the renal proximal tubular cell line OK is also associ-
ated with system bo,1-like activity, with characteristics of
obligatory amino acid exchange.
We have also shown that the amino acid exchange activity of
system bo,1-like is tightly coupled and allows intracellular con-
centration of amino acid substrates until the complete replace-
ment of the internal system bo,1-like substrates of the oocyte.
The maximum level of accumulation of substrates via system
bo,1-like (;1,000 pmol/oocyte) fits well with the reported con-
tent of free amino acid substrates of this system in stage VI
oocytes (31). Interestingly, the level of accumulation of sub-
strates at low mM concentration reached in rBAT-injected oo-
cytes exceeds that obtained in uninjected or in CAT1-injected
oocytes (i.e. expressing system y1 amino acid transport activi-
ty). In contrast to system bo,1-like, system y1 is an equilibra-
tive transport activity that shows a high trans-stimulation
effect (Ref. 24; 6-fold in CAT1-injected oocytes, data not
shown), but with significant transport activity in the absence of
substrates on the trans-side (24, 39), and which leads to a
higher accumulation of substrates than that given by the mem-
brane potential in oocytes (present study) and in fibroblasts
(40). All this strongly suggests that system bo,1-like should be
considered as a tertiary active transporter. In contrast, pri-
mary and secondary active transport mechanisms could not
explain accumulation of substrates via system bo,1-like for the
following reasons. (i) The cut-open oocyte model is able to show
system bo,1-like activity in rBAT-injected oocytes without the
addition of triphosphate nucleotides to the external perfusion
system (16). (ii) Sodium is not necessary for the accumulation
of substrates via system bo,1-like (present study), and neither
sodium, potassium, nor chloride ions are needed for system
bo,1-like activity in oocytes (11, 16, 23). Rennie and collabora-
tors (17) suggested hetero-exchange of neutral amino acids
(inward) and potassium (outward) in rat rBAT-injected oocytes.
In contrast, both for human and for rabbit rBAT-injected oo-
cytes, potassium does not affect the currents induced by L-
arginine or L-leucine (15).2 In conclusion, system bo,1-like, as-
sociated with rBAT expression, is a tightly coupled exchanger
with 1:1 stoichiometry. Whether system bo,1-like has a con-
certed or a ping-pong mechanism of exchange is beyond the
scope of the present study and needs further research.
Here we provide evidence that system y1L-like, associated
with 4F2hc expression in oocytes, is an obligatory amino acid
exchanger that mediates efflux of dibasic amino acids (e.g.
L-arginine) and, in the presence of sodium, influx of neutral
amino acids at mM concentration. It has been suggested (41)
that the amino acid transport activity associated with human
4F2hc expression in oocytes is identical to the y1L activity
described in human erythrocytes and placenta (36–38, 42). In
contrast to this general system, y1L shows transport activity in
the absence of substrates in the trans-side, as an equilibrative
transporter with trans-stimulation (36–38). It is also possible
that system y1L may indeed be an obligatory exchanger be-
cause the functional isolation of system y1L from the co-exist-
ing system y1 in erythrocytes has been accomplished by NEM
treatment, since the latter system is sensitive to the reagent,
whereas the former system is resistant (42). A possible modi-
fication of the hypothetical coupled exchange mechanism of
transport of system y1L by NEM treatment has not been ruled
out. In fact, mitochondrial exchangers, such as the ATD/ADP
carrier, act as equilibrative transport systems after sulfhydryl
reagent treatment (43).
To our knowledge this is the first study demonstrating active
transport via systems y1L-like and bo,1-like, associated with
4F2hc and rBAT expression in oocytes, respectively. These two
amino acid transport systems are very alike. (i) Both are high
affinity systems with a broad specificity for dibasic and neutral
amino acids. (ii) Both proteins are homologous, with a similar
hydrophobicity profile and most probably linked by disulfide
bridges to putative “light” subunits of 30–50 kDa (44–45). This
fostered the hypothesis that both transporters are het-
erodimeric, both subunits being essential, but not sufficient, for
the transport activity of systems bo,1-like and y1L-like (46).
The tertiary active transport mechanism shown here for these
two transport systems indicates that they belong to a common
family of obligatory amino acid exchangers.
A Role for the Amino Acid Exchanger Systems bo,1-like and
y1L-like in Renal Reabsorption—Recent studies have demon-
strated that the human rBAT gene is responsible for type I
cystinuria (1, 7–8). Patients show hyperexcretion of dibasic
amino acids and cystine, but not of neutral amino acids, due to
a defect in the active reabsorption of those amino acids in
kidney (4). The tertiary active transport mechanism of the high
affinity system bo,1-like, described here, explains the respon-
sibility of rBAT in cystinuria. We propose a model for the role
of system bo,1-like (rBAT) in the active renal reabsorption of
cystine and dibasic amino acids by obligatory exchange with
intracellular neutral amino acids (Fig. 8). The direction of
2 A. E. Busch, unpublished results.
FIG. 7. L- [3H]Arginine efflux via amino acid transport system
y1L-like in oocytes. Oocytes were injected with 1 ng of 4F2hc cRNA
(black bars). Uninjected oocytes (open bars) were used as controls. Four
days after, rates of L-[3H]arginine or L-[3H]leucine efflux into sodium or
choline medium were measured. In addition, medium contained no
amino acids (none) or L-amino acids at the indicated concentrations
(mM). Efflux rates are expressed as the radioactivity (cpm 3 1,000)
appearing in the medium/5 min per group of 6 or 7 oocytes. A,
L-[3H]arginine efflux rates. Data correspond to the mean 6 S.E. of
triplicates from a representative experiment. The presence of L-arginine
(Arg) and L-leucine (Leu), but not L-tryptophan (Trp), in the medium
increased significantly efflux by 4F2hc cRNA-injected, but not by un-
injected, oocytes (p # 0.05). B, L-[3H]leucine efflux rates. Efflux rates by
4F2hc-injected and uninjected oocytes in the presence of L-arginine
(Arg) were similar to those in the absence of amino acids or in the
presence of tryptophan (Trp). Data correspond to the mean 6 S.E. from
triplicates from a representative experiment. Another 3 independent
experiments gave similar results.
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exchange dibasic-inward/neutral-outward has been shown to
be favored in the present study and agrees with the fact that
hyperexcretion of neutral amino acids does not occur in cystin-
uric patients. The negative membrane potential, the intracel-
lular reduction of L-cystine to L-cysteine, and the high intracel-
lular concentration of neutral amino acids, which are
substrates for system bo,1-like, may be the determinants of the
reabsorption of L-dibasic amino acids and L-cystine via system
bo,1-like. The tightly coupled mechanism of obligatory ex-
change of system bo,1-like would ensure efficient active reab-
sorption of cystine and dibasic amino acids. In addition this
mechanism would prevent the net loss of amino acids via sys-
tem bo,1-like toward the lumen at the end of the proximal
straight tubule, where rBAT is expressed (9–10) and a low
concentration of amino acids is present. Further studies are
needed to examine the factors affecting the activity and the
direction of amino acid exchange via system bo,1-like.
The obligatory exchange of amino acids via system y1L-like,
associated with 4F2hc expression in oocytes, may have impor-
tant physiological consequences. It has been reported that ef-
flux across the basolateral membrane is the rate-limiting step
in the intestinal absorption of dibasic amino acids (48–49).
Furthermore, leucine at low mM concentration increases (6–10-
fold) the trans-epithelial flux of lysine (49–50). Countertrans-
port between lysine (outward) and leucine (inward) or alloster-
ism were considered to be responsible for this process. System
y1L can sustain lysine-leucine exchange with an apparent Km
for leucine of ;10 mM in the presence of sodium (36). If such a
system is found in the basolateral membranes of intestinal or
renal epithelial cells, system y1L will support the counter-
transport hypothesis (37). The surface antigen 4F2hc has a
basolateral localization in renal epithelial cells from the prox-
imal tubule (51). System y1L-like, associated with 4F2hc ex-
pression, could be responsible for the active release of dibasic
amino acids through the basolateral membrane of epithelial
cells (Fig. 8). The evidence offered here, that the direction of
exchange that is favored is L-arginine (outward) with low mM
concentration of leucine (inward) in the presence of sodium,
strongly supports this hypothesis. Further research is needed
to elucidate the mechanism (e.g. a weak interaction of neutral
amino acids from inside due to the low intracellular concentra-
tion of sodium) responsible for this asymmetric exchange.
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42. Devés, R., Angelo, S., and Chávez, P. (1993) J. Physiol. (Lond.) 468, 753–766
43. Dierks, T., Salentin, A., Heberger, C., and Krämer, R. (1990) Biochim. Biophys.
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